Status:
COMPLETED
Holter and ECG Changes After Trancatheter Closure Of ASD In Children
Lead Sponsor:
Sohag University
Conditions:
ASD II
Eligibility:
All Genders
Up to 18 years
Brief Summary
Atrial septal defects (ASD) account for 10% of all congenital heart defects . Hemodynamic consequences of an ASD are dilatation of the right atrium and right ventricle (RV) because of the volume overl...
Eligibility Criteria
Inclusion
- All children under the age of 18 years diagnosed with ASD , that will undergo transcatheter secundum ASD device closure during the period of the study .
Exclusion
- Failure to obtain informed consent .
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06197191
Start Date
April 1 2022
End Date
May 15 2023
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University Hospital
Sohag, Sohag Governorate, Egypt